0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lanthanum Carbonate Chewable Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-7L17178
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Lanthanum Carbonate Chewable Tablets Market Research Report 2024
BUY CHAPTERS

Global Lanthanum Carbonate Chewable Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7L17178
Report
November 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lanthanum Carbonate Chewable Tablets Market

The global Lanthanum Carbonate Chewable Tablets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Lanthanum carbonate chewable tablets are a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD).
From a downstream perspective, Hospital Pharmaty accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Lanthanum Carbonate Chewable Tablets leading manufacturers including Shire Pharmaceuticals, Teva Pharmaceuticals, Mylan, Shenyang Funing Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Hunan Zhengtai Jinhu Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Shire Pharmaceuticals leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Lanthanum Carbonate Chewable Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Specification and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Lanthanum Carbonate Chewable Tablets Market Report

Report Metric Details
Report Name Lanthanum Carbonate Chewable Tablets Market
Segment by Specification
  • 500 mg
  • 750 mg
  • 1000 mg
Segment by Application
  • Hospital Pharmaty
  • Retail Pharmaty
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shire Pharmaceuticals, Teva Pharmaceuticals, Mylan, Shenyang Funing Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Hunan Zhengtai Jinhu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Lanthanum Carbonate Chewable Tablets study scope, segments the market by Specification and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Specification, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Specification, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Specification, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Specification, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Specification, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Lanthanum Carbonate Chewable Tablets Market report?

Ans: The main players in the Lanthanum Carbonate Chewable Tablets Market are Shire Pharmaceuticals, Teva Pharmaceuticals, Mylan, Shenyang Funing Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Hunan Zhengtai Jinhu Pharmaceutical

What are the Application segmentation covered in the Lanthanum Carbonate Chewable Tablets Market report?

Ans: The Applications covered in the Lanthanum Carbonate Chewable Tablets Market report are Hospital Pharmaty, Retail Pharmaty

1 Study Coverage
1.1 Introduction to Lanthanum Carbonate Chewable Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Specification
1.2.1 Global Lanthanum Carbonate Chewable Tablets Market Size by Specification, 2020 VS 2024 VS 2031
1.2.2 500 mg
1.2.3 750 mg
1.2.4 1000 mg
1.3 Market Segmentation by Application
1.3.1 Global Lanthanum Carbonate Chewable Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmaty
1.3.3 Retail Pharmaty
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lanthanum Carbonate Chewable Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Lanthanum Carbonate Chewable Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Lanthanum Carbonate Chewable Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Lanthanum Carbonate Chewable Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Lanthanum Carbonate Chewable Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Lanthanum Carbonate Chewable Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 500 mg Market Size by Manufacturers
3.5.2 750 mg Market Size by Manufacturers
3.5.3 1000 mg Market Size by Manufacturers
3.6 Global Lanthanum Carbonate Chewable Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Lanthanum Carbonate Chewable Tablets Sales Performance by Specification
4.1.1 Global Historical and Forecasted Sales by Specification (2020-2031)
4.1.2 Global Sales Market Share by Specification (2020-2031)
4.2 Global Lanthanum Carbonate Chewable Tablets Revenue Trends by Specification
4.2.1 Global Historical and Forecasted Revenue by Specification (2020-2031)
4.2.2 Global Revenue Market Share by Specification (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Specification (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Lanthanum Carbonate Chewable Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Lanthanum Carbonate Chewable Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Lanthanum Carbonate Chewable Tablets Sales and Revenue by Specification (2020-2031)
6.4 North America Lanthanum Carbonate Chewable Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Lanthanum Carbonate Chewable Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Lanthanum Carbonate Chewable Tablets Sales and Revenue by Specification (2020-2031)
7.4 Europe Lanthanum Carbonate Chewable Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Lanthanum Carbonate Chewable Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales and Revenue by Specification (2020-2031)
8.4 Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Lanthanum Carbonate Chewable Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Lanthanum Carbonate Chewable Tablets Sales and Revenue by Specification (2020-2031)
9.4 Central and South America Lanthanum Carbonate Chewable Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Lanthanum Carbonate Chewable Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Lanthanum Carbonate Chewable Tablets Sales and Revenue by Specification (2020-2031)
10.4 Middle East and Africa Lanthanum Carbonate Chewable Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Lanthanum Carbonate Chewable Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Shire Pharmaceuticals
11.1.1 Shire Pharmaceuticals Corporation Information
11.1.2 Shire Pharmaceuticals Business Overview
11.1.3 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.1.4 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Product in 2024
11.1.6 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Application in 2024
11.1.7 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Geographic Area in 2024
11.1.8 Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets SWOT Analysis
11.1.9 Shire Pharmaceuticals Recent Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Corporation Information
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.2.4 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Product in 2024
11.2.6 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Application in 2024
11.2.7 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets Sales by Geographic Area in 2024
11.2.8 Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets SWOT Analysis
11.2.9 Teva Pharmaceuticals Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Business Overview
11.3.3 Mylan Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.3.4 Mylan Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mylan Lanthanum Carbonate Chewable Tablets Sales by Product in 2024
11.3.6 Mylan Lanthanum Carbonate Chewable Tablets Sales by Application in 2024
11.3.7 Mylan Lanthanum Carbonate Chewable Tablets Sales by Geographic Area in 2024
11.3.8 Mylan Lanthanum Carbonate Chewable Tablets SWOT Analysis
11.3.9 Mylan Recent Developments
11.4 Shenyang Funing Pharmaceutical
11.4.1 Shenyang Funing Pharmaceutical Corporation Information
11.4.2 Shenyang Funing Pharmaceutical Business Overview
11.4.3 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.4.4 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Product in 2024
11.4.6 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Application in 2024
11.4.7 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Geographic Area in 2024
11.4.8 Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets SWOT Analysis
11.4.9 Shenyang Funing Pharmaceutical Recent Developments
11.5 Nanjing Zhengda Tianqing Pharmaceutical
11.5.1 Nanjing Zhengda Tianqing Pharmaceutical Corporation Information
11.5.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
11.5.3 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.5.4 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Product in 2024
11.5.6 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Application in 2024
11.5.7 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales by Geographic Area in 2024
11.5.8 Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets SWOT Analysis
11.5.9 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
11.6 Hunan Zhengtai Jinhu Pharmaceutical
11.6.1 Hunan Zhengtai Jinhu Pharmaceutical Corporation Information
11.6.2 Hunan Zhengtai Jinhu Pharmaceutical Business Overview
11.6.3 Hunan Zhengtai Jinhu Pharmaceutical Lanthanum Carbonate Chewable Tablets Product Models, Descriptions and Specifications
11.6.4 Hunan Zhengtai Jinhu Pharmaceutical Lanthanum Carbonate Chewable Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hunan Zhengtai Jinhu Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Lanthanum Carbonate Chewable Tablets Industry Chain
12.2 Lanthanum Carbonate Chewable Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Lanthanum Carbonate Chewable Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Lanthanum Carbonate Chewable Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Lanthanum Carbonate Chewable Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Lanthanum Carbonate Chewable Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Lanthanum Carbonate Chewable Tablets Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Lanthanum Carbonate Chewable Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Lanthanum Carbonate Chewable Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Lanthanum Carbonate Chewable Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Lanthanum Carbonate Chewable Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Lanthanum Carbonate Chewable Tablets Sales by Region (2020-2025) & (K Units)
 Table 8. Global Lanthanum Carbonate Chewable Tablets Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Lanthanum Carbonate Chewable Tablets Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Lanthanum Carbonate Chewable Tablets Sales Share by Manufacturers (2020-2025)
 Table 12. Global Lanthanum Carbonate Chewable Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Lanthanum Carbonate Chewable Tablets Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Lanthanum Carbonate Chewable Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lanthanum Carbonate Chewable Tablets as of 2024)
 Table 16. Global Lanthanum Carbonate Chewable Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Lanthanum Carbonate Chewable Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Lanthanum Carbonate Chewable Tablets Manufacturing Base and Headquarters
 Table 19. Global Lanthanum Carbonate Chewable Tablets Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Lanthanum Carbonate Chewable Tablets Sales by Specification (2020-2025) & (K Units)
 Table 23. Global Lanthanum Carbonate Chewable Tablets Sales by Specification (2026-2031) & (K Units)
 Table 24. Global Lanthanum Carbonate Chewable Tablets Revenue by Specification (2020-2025) & (US$ Million)
 Table 25. Global Lanthanum Carbonate Chewable Tablets Revenue by Specification (2026-2031) & (US$ Million)
 Table 26. Global Lanthanum Carbonate Chewable Tablets ASP by Specification (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Lanthanum Carbonate Chewable Tablets Sales by Application (2020-2025) & (K Units)
 Table 29. Global Lanthanum Carbonate Chewable Tablets Sales by Application (2026-2031) & (K Units)
 Table 30. Lanthanum Carbonate Chewable Tablets High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Lanthanum Carbonate Chewable Tablets Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Lanthanum Carbonate Chewable Tablets Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Lanthanum Carbonate Chewable Tablets ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Lanthanum Carbonate Chewable Tablets Growth Accelerators and Market Barriers
 Table 37. North America Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Lanthanum Carbonate Chewable Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Lanthanum Carbonate Chewable Tablets Growth Accelerators and Market Barriers
 Table 40. Europe Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Lanthanum Carbonate Chewable Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Lanthanum Carbonate Chewable Tablets Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Lanthanum Carbonate Chewable Tablets Investment Opportunities and Key Challenges
 Table 47. Central and South America Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Lanthanum Carbonate Chewable Tablets Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Lanthanum Carbonate Chewable Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Shire Pharmaceuticals Corporation Information
 Table 51. Shire Pharmaceuticals Description and Major Businesses
 Table 52. Shire Pharmaceuticals Product Models, Descriptions and Specifications
 Table 53. Shire Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Shire Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 55. Shire Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 56. Shire Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 57. Shire Pharmaceuticals Lanthanum Carbonate Chewable Tablets SWOT Analysis
 Table 58. Shire Pharmaceuticals Recent Developments
 Table 59. Teva Pharmaceuticals Corporation Information
 Table 60. Teva Pharmaceuticals Description and Major Businesses
 Table 61. Teva Pharmaceuticals Product Models, Descriptions and Specifications
 Table 62. Teva Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Teva Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 64. Teva Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 65. Teva Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 66. Teva Pharmaceuticals Lanthanum Carbonate Chewable Tablets SWOT Analysis
 Table 67. Teva Pharmaceuticals Recent Developments
 Table 68. Mylan Corporation Information
 Table 69. Mylan Description and Major Businesses
 Table 70. Mylan Product Models, Descriptions and Specifications
 Table 71. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Mylan Sales Value Proportion by Product in 2024
 Table 73. Mylan Sales Value Proportion by Application in 2024
 Table 74. Mylan Sales Value Proportion by Geographic Area in 2024
 Table 75. Mylan Lanthanum Carbonate Chewable Tablets SWOT Analysis
 Table 76. Mylan Recent Developments
 Table 77. Shenyang Funing Pharmaceutical Corporation Information
 Table 78. Shenyang Funing Pharmaceutical Description and Major Businesses
 Table 79. Shenyang Funing Pharmaceutical Product Models, Descriptions and Specifications
 Table 80. Shenyang Funing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Shenyang Funing Pharmaceutical Sales Value Proportion by Product in 2024
 Table 82. Shenyang Funing Pharmaceutical Sales Value Proportion by Application in 2024
 Table 83. Shenyang Funing Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 84. Shenyang Funing Pharmaceutical Lanthanum Carbonate Chewable Tablets SWOT Analysis
 Table 85. Shenyang Funing Pharmaceutical Recent Developments
 Table 86. Nanjing Zhengda Tianqing Pharmaceutical Corporation Information
 Table 87. Nanjing Zhengda Tianqing Pharmaceutical Description and Major Businesses
 Table 88. Nanjing Zhengda Tianqing Pharmaceutical Product Models, Descriptions and Specifications
 Table 89. Nanjing Zhengda Tianqing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Nanjing Zhengda Tianqing Pharmaceutical Sales Value Proportion by Product in 2024
 Table 91. Nanjing Zhengda Tianqing Pharmaceutical Sales Value Proportion by Application in 2024
 Table 92. Nanjing Zhengda Tianqing Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 93. Nanjing Zhengda Tianqing Pharmaceutical Lanthanum Carbonate Chewable Tablets SWOT Analysis
 Table 94. Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
 Table 95. Hunan Zhengtai Jinhu Pharmaceutical Corporation Information
 Table 96. Hunan Zhengtai Jinhu Pharmaceutical Description and Major Businesses
 Table 97. Hunan Zhengtai Jinhu Pharmaceutical Product Models, Descriptions and Specifications
 Table 98. Hunan Zhengtai Jinhu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Hunan Zhengtai Jinhu Pharmaceutical Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Lanthanum Carbonate Chewable Tablets Product Picture
 Figure 2. Global Lanthanum Carbonate Chewable Tablets Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 500 mg Product Picture
 Figure 4. 750 mg Product Picture
 Figure 5. 1000 mg Product Picture
 Figure 6. Global Lanthanum Carbonate Chewable Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital Pharmaty
 Figure 8. Retail Pharmaty
 Figure 9. Lanthanum Carbonate Chewable Tablets Report Years Considered
 Figure 10. Global Lanthanum Carbonate Chewable Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Lanthanum Carbonate Chewable Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Lanthanum Carbonate Chewable Tablets Revenue Market Share by Region (2020-2031)
 Figure 14. Global Lanthanum Carbonate Chewable Tablets Sales (2020-2031) & (K Units)
 Figure 15. Global Lanthanum Carbonate Chewable Tablets Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Lanthanum Carbonate Chewable Tablets Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Volume Market Share in 2024
 Figure 18. Global Lanthanum Carbonate Chewable Tablets Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 500 mg Revenue Market Share by Manufacturer in 2024
 Figure 21. 750 mg Revenue Market Share by Manufacturer in 2024
 Figure 22. 1000 mg Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Lanthanum Carbonate Chewable Tablets Sales Market Share by Specification (2020-2031)
 Figure 24. Global Lanthanum Carbonate Chewable Tablets Revenue Market Share by Specification (2020-2031)
 Figure 25. Global Lanthanum Carbonate Chewable Tablets Sales Market Share by Application (2020-2031)
 Figure 26. Global Lanthanum Carbonate Chewable Tablets Revenue Market Share by Application (2020-2031)
 Figure 27. North America Lanthanum Carbonate Chewable Tablets Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Lanthanum Carbonate Chewable Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) in 2024
 Figure 30. North America Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Specification (2020- 2031)
 Figure 31. North America Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Specification (2020 - 2031)
 Figure 32. North America Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Lanthanum Carbonate Chewable Tablets Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Lanthanum Carbonate Chewable Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Specification (2020-2031)
 Figure 41. Europe Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 42. Europe Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 45. France Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Lanthanum Carbonate Chewable Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Specification (2020- 2031)
 Figure 53. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Specification (2020- 2031)
 Figure 54. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 60. India Lanthanum Carbonate Chewable Tablets Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Lanthanum Carbonate Chewable Tablets Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Lanthanum Carbonate Chewable Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Specification (2021-2031)
 Figure 65. Central and South America Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 66. Central and South America Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Lanthanum Carbonate Chewable Tablets Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Lanthanum Carbonate Chewable Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Specification (2021-2031)
 Figure 74. South America Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 75. Middle East and Africa Lanthanum Carbonate Chewable Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Lanthanum Carbonate Chewable Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Lanthanum Carbonate Chewable Tablets Revenue (2020-2025) & (US$ Million)
 Figure 81. Lanthanum Carbonate Chewable Tablets Industry Chain Mapping
 Figure 82. Regional Lanthanum Carbonate Chewable Tablets Manufacturing Base Distribution (%)
 Figure 83. Global Lanthanum Carbonate Chewable Tablets Production Market Share by Region (2020-2031)
 Figure 84. Lanthanum Carbonate Chewable Tablets Production Process
 Figure 85. Regional Lanthanum Carbonate Chewable Tablets Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart